ISRCTN35745418
Active, not recruiting
未知
Measuring the impact of improved diagnostics on antimicrobial stewardship in respiratory tract infection (MIDAS Study)
HS Lothian0 sites600 target enrollmentJuly 18, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- HS Lothian
- Enrollment
- 600
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 and over
- •2\. Hospitalised
- •3\. Lower respiratory tract specimen taken for routine microbiology within 48 hours of admission and \- 3 or more of following signs or symptoms of respiratory tract infection:
- •\-new or worsening cough
- •\-new or worsening expectoration of sputum
- •\-haemoptysis
- •\-new or worsening dyspnea
- •\-pleuritic chest pain
- •\-abnormalities on chest auscultation or percussion
Exclusion Criteria
- •1\. Hospitalisation for more than 48 hours
- •2\. No capacity to consent
- •3\. Active malignancy
- •4\. Immunodeficiency \- defined as being on long term (?28 days) oral prednisolone 10mg or more per day or other long term disease modifying drug
- •5\. Solid organ transplant
- •6\. All forms of pulmonary fibrosis including usual interstitial pneumonia, asbestosis, non\-specific interstitial pneumonia, hypersensitivity pneumonitis, active sarcoidosis
- •7\. Palliative treatment only
- •8\. Mechanical ventilation
- •9\. End of life care
- •10\. Previously randomised into this trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Access to diagnostic innovation essential for prevention of antimicrobial resistanceHealth Condition 1: R509- Fever, unspecifiedCTRI/2020/04/024681Foundation for Innovative New Diagnostics FIND
Recruiting
Not Applicable
A study on improving the diagnostic performance of mild cognitive impairment using Multi-PLD ASJPRN-jRCT1020210069Sasaki Makoto190
Not yet recruiting
Not Applicable
Advancing Access to Diagnostic Innovation essential For AMR PreventioCTRI/2020/02/023253Foundation for Innovative New Diagnostics
Completed
Not Applicable
Advancing access to diagnostic innovation essential foruniversal health coverage and anti-microbial resistance preventioHealth Condition 1: R509- Fever, unspecifiedCTRI/2020/05/025193Indian Council of Medical Research2,816
Completed
Not Applicable
Evaluation of the effect of the diagnostic and therapeutic advices given by an Asthma/chronic obstructive pulmonary disease (COPD) service on the referring general practitioners and their patientsAsthma, chronic obstructive pulmonary disease (COPD)RespiratoryOther chronic obstructive pulmonary diseaseISRCTN45174826Care and Public Health Research Institute (CAPHRI) (The Netherlands)1,000